<SEC-DOCUMENT>0001513162-20-000010.txt : 20200109
<SEC-HEADER>0001513162-20-000010.hdr.sgml : 20200109
<ACCEPTANCE-DATETIME>20200109161748
ACCESSION NUMBER:		0001513162-20-000010
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200109
DATE AS OF CHANGE:		20200109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anixa Biosciences Inc
		CENTRAL INDEX KEY:			0000715446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				112622630
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-227653
		FILM NUMBER:		20518370

	BUSINESS ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118
		BUSINESS PHONE:		408-708-9808

	MAIL ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ITUS Corp
		DATE OF NAME CHANGE:	20140902

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPYTELE INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>424b3.htm
<DESCRIPTION>424(B)(3)
<TEXT>
<HTML>
<head><title>Form S-8</title> </head> <body vlink=purple link=blue bgcolor=white lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b><font style="FONT-SIZE:10pt; COLOR:black">Filed Pursuant to Rule 424(b)(3) </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b><font style="FONT-SIZE:10pt; COLOR:black">Registration No.&nbsp; 333-</font></b> <b><font style="FONT-SIZE:10pt; COLOR:black">227653 </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5pt 0pt 0in' align=right><b></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:12pt 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Prospectus Supplement No.&nbsp;1 to Reoffer Prospectus </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:6pt 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">of </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:6pt 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Anixa Biosciences, Inc. </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:6pt 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Up to 7,030,112 Shares of Common Stock</font></b> <b><font style="FONT-SIZE:10pt; COLOR:black">under the 2018 Share Incentive Plan, Employee Stock Purchase Plan, 2010 Share Incentive Plan, as amended, certain Non-Plan Time Based Stock Option Agreements and certain Non-Plan Performance Based Stock Option Agreements </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><font style="FONT-SIZE:10pt; COLOR:black">This Prospectus Supplement, dated January 9, 2020 (this &#147;Supplement&#148;), supplements the reoffer prospectus filed as part of the Registration Statement on Form S-8 filed by Anixa Biosciences, Inc. (the &#147;Company&#148;</font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">, &#147;us&#148;, &#147;our&#148; or &#147;we&#148;</font><font style="FONT-SIZE:10pt; COLOR:black">) with the Securities and Exchange Commission (the &#147;SEC&#148;) on October 1, 2018 (the &#147;Prospectus&#148;), relating to the resale of common stock, par value $0.01 per share (the &#147;Common Stock&#148;), of the Company which may be offered and sold from time to time by certain of our executive officers and directors (the &#147;Selling Stockholders&#148;) who may be deemed &#147;affiliates&#148; of the Company as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), who have acquired or will acquire such shares in connection with the exercise of stock options granted, and with stock or other awards made, and with the purchase of stock under, the Company&#146;s 2018 Share Incentive Plan (the &#147;2018 Plan&#148;), the Company&#146;s Employee Stock Purchase Plan (the &#147;ESPP&#148;), the Company&#146;s 2010 Share Incentive Plan, as amended (the &#147;2010 Plan&#148;), as well as certain Non-Plan Time Based Stock Option Agreements between the Company and certain Selling Stockholders (each a &#147;Time Based Stock Option Agreement&#148;) and certain Non-Plan Performance Based Stock Option Agreements between the Company and certain Selling Stockholders (each a &#147;Performance Based Stock Option Agreement&#148; and together with each of the Time Based Option Agreements, the &#147;Option Agreements&#148;). This Supplement covers 7,030,112 shares of Common Stock (the &#147;Shares&#148;) including </font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">(i) shares of Common Stock (inclusive of shares purchased pursuant to the ESPP and restricted shares granted under the 2018 Plan) and (ii) shares issuable upon exercise of options granted to such Selling Stockholders under the 2018 Plan, the 2010 Plan and the Option Agreements </font><font style="FONT-SIZE:10pt; COLOR:black"> that are owned by the Selling Stockholders. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><font style="FONT-SIZE:10pt; COLOR:black">You should read this Supplement in conjunction with the Prospectus. This Supplement is qualified by reference to the Prospectus, except to the extent the information in this Supplement supersedes the information contained in the Prospectus. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><font style="FONT-SIZE:10pt; COLOR:black">Our Common Stock is quoted on the Nasdaq Capital Market under the symbol &#147;ANIX&#148;. On January 8, 2020, the closing sales price of our Common Stock on the Nasdaq Capital Market was $3.00 per share. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The Shares may be offered from time to time by any or all of the Selling Stockholders through ordinary brokerage transactions, in negotiated transactions or in other transactions, at such prices as such Selling Stockholder may determine, which may relate to market prices prevailing at the time of&nbsp;sale or be a negotiated price. See &#147;Plan of Distribution&#148; in the Prospectus. Sales may be made through brokers or to dealers, who are expected to receive customary commissions or discounts.</font><font style="FONT-SIZE:10pt; COLOR:black"> We will not control or determine the price at which a Selling Stockholder decides to sell its shares. Brokers or dealers effecting transactions in these shares should confirm that the shares are registered under applicable state law or that an exemption from registration is available. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The Selling Stockholders and participating brokers and dealers may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act, in which event any profit on the sale of shares of those Selling Stockholders and any commissions or discounts received by those brokers or dealers may be deemed to be underwriting compensation under the Securities Act.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><b><font style="FONT-SIZE:10pt; COLOR:black">You should carefully read and consider the risk factors under Item&nbsp;1A beginning on page 17 of our Annual Report on Form 10-K for the year ended October 31, 2019 for risks relating to investment in the Company&#146;s securities. </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:12pt 0in 0pt' align=center><font style=FONT-SIZE:10pt>1</font> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of the Prospectus or this Supplement. Any representation to the contrary is a criminal offense. </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:24.5pt'><font style="FONT-SIZE:10pt; COLOR:black">The information set forth under the caption &#147;Selling Stockholders&#148; in the Prospectus is amended and restated in its entirety as set forth below and is provided for the primary purpose of updating the table of selling stockholders contained in the Prospectus. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The date of this Supplement is January 9, 2020</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <div> <div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>&nbsp; </font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font></p></div></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>SELLING STOCKHOLDERS</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in'><a name=page_0_1_19 /><font style="FONT-SIZE:10pt; COLOR:black">The following table sets forth (a) the name and position or positions with the Company of each Selling Stockholder; (b) the aggregate of (i) the number of shares of Common Stock held by each Selling Stockholder as of the date of this Supplement (including shares purchased pursuant to the ESPP) and (ii) the number of shares issuable upon exercise of options granted to each Selling Stockholder under the 2018 Plan, the 2010 Plan and the Option Agreements that are being registered pursuant to the Prospectus, as supplemented by this Supplement, for resale by each Selling Stockholder as of the date of this Supplement; (c) the number of shares of Common Stock that each Selling Stockholder may offer for sale from time to time pursuant to the Prospectus, as supplemented by this Supplement, whether or not such Selling Stockholder has a present intention to do so; and (d) the number of shares of Common Stock to be beneficially owned by each Selling Stockholder following the sale of all shares that may be so offered pursuant to the Prospectus, as supplemented by this Supplement, assuming no other change in ownership of Common Stock by such Selling Stockholder after the date of this Supplement. Unless otherwise indicated, beneficial ownership is direct and the person indicated has sole voting and investment power.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">To our knowledge, none of our officers and directors have a present intention to offer shares of Common stock for sale, although they retain the right to do so.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Inclusion of an individual&#146;s name in the table below does not constitute an admission that such individual is an &#147;affiliate&#148; of the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=19% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 6.4pt' align=center><b><font style=FONT-SIZE:10pt>Selling Stockholder</font></b></p></td> <td width=22% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Principal Position with the Company (1)</font></b></p></td> <td width=24% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:24.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Shares Owned Prior to Resale</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>(2)(3)(4)(5)(6)(7)</font></b></p></td> <td width=13% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Number of Shares Offered for Resale</font></b></p></td> <td width=20% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:20.7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Shares Beneficially Owned After Resale</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>(7)</font></b></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Number</font></b></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Percent</font></b></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Number</font></b></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><b><font style=FONT-SIZE:10pt>Percent</font></b></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Dr. Amit Kumar</font></p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>President, Chief Executive</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Officer and Chairman</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>of the Board</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>5,174,000</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>21.27%</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>5,000,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>174,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael J. Catelani</font></p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Chief Financial Officer and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Chief Operating Officer</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>853,962</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>3.94%</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>851,712</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>2,250</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Lewis H. Titterton, Jr.</font></p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>1,561,544</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>7.27%</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>707,400</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>854,144</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>3.98%</font></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Dr. John Monahan</font></p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>208,900</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>1.00%</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>208,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>900</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Dr. Arnold Baskies</font></p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>139,000</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>128,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>11,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>David Cavalier</font></p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>92,000</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>90,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>2,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:19.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Emily Gottschalk</font></p></td> <td width=22% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>45,000</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:13.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>45,000</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>&#150;</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:10.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.4pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><u><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><font style="FONT-SIZE:10pt; COLOR:black">* &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Less than 1%.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">(1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">All positions described are with the Company, unless otherwise indicated.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">(2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">The number of shares owned prior to resale by each Selling Stockholder includes (i) shares of Common Stock (inclusive of shares purchased pursuant to the ESPP </font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black"> and restricted shares granted under the 2018 Plan</font><font style="FONT-SIZE:10pt; COLOR:black">) and (ii) shares issuable upon exercise of options granted to such Selling Stockholders under the 2018 Plan, the 2010 Plan and the Option Agreements that are being registered pursuant to the Prospectus, as supplemented by this Supplement, for resale. Some of these shares may have been sold prior to the date of this Supplement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">(3)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Includes 1,500,000 restricted shares of Common Stock awarded to Dr. Amit Kumar pursuant to the 2018 Plan for which Dr. Kumar has voting rights but that vest only if during any 20 trading day period on or before May 31, 2021 in which Dr. Kumar is employed by the Company, the average closing stock price of the issuer's common stock is at least $11.00.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">3</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">(4)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Includes 2,620,000 shares, 600,000 shares, 45,000 shares, 45,000 shares, 45,000 shares, 45,000 shares, 45,000 shares and 3,445,000 shares which Dr. Amit Kumar, Michael J. Catelani, Lewis H. Titterton, Jr., Dr. John Monahan, Dr. Arnold Baskies, David Cavalier, Emily Gottschalk and all directors and executive officers as a group, respectively, have the right to acquire upon exercise of options granted pursuant to the 2018 Plan.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">(5)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Includes 240,000 shares, 250,000 shares, 524,000 shares, 113,000 shares, 83,000 shares, 45,000 shares and 1,255,000 shares which Dr. Amit Kumar, Michael J. Catelani, Lewis H. Titterton, Jr., Dr. John Monahan, Dr. Arnold Baskies, David Cavalier and all directors and executive officers as a group, respectively, have the right to acquire upon exercise of options granted pursuant to the 2010 Plan.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">(6)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Includes 640,000 shares, 86,000 shares, and 726,000 shares which Dr. Amit Kumar, Lewis H. Titterton, Jr. and all directors and executive officers as a group, respectively, have the right to acquire pursuant to the Option Agreements with the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">(7)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Percentage is computed with reference to 20,821,204 shares of our Common Stock outstanding as of January 8, 2020 and assumes for each Selling Stockholder the sale of all shares offered by that particular Selling Stockholder under the Prospectus and this Supplement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>4</font></p></div></body>
<!-- EDGAR Validation Code: 31120443 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
